vs
Side-by-side financial comparison of Organon & Co. (OGN) and Sally Beauty Holdings, Inc. (SBH). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $943.2M, roughly 1.6× Sally Beauty Holdings, Inc.). Sally Beauty Holdings, Inc. runs the higher net margin — 4.8% vs -13.6%, a 18.4% gap on every dollar of revenue. On growth, Sally Beauty Holdings, Inc. posted the faster year-over-year revenue change (0.6% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $57.5M). Over the past eight quarters, Sally Beauty Holdings, Inc.'s revenue compounded faster (1.9% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Sally Beauty Holdings, Inc. is an American international specialty retailer and distributor of professional beauty supplies with revenues of more than $3.9 billion annually.
OGN vs SBH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $943.2M |
| Net Profit | $-205.0M | $45.6M |
| Gross Margin | 49.2% | 51.2% |
| Operating Margin | -9.8% | 8.1% |
| Net Margin | -13.6% | 4.8% |
| Revenue YoY | -5.3% | 0.6% |
| Net Profit YoY | -288.1% | -25.3% |
| EPS (diluted) | $-0.78 | $0.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $943.2M | ||
| Q3 25 | $1.6B | $947.1M | ||
| Q2 25 | $1.6B | $933.3M | ||
| Q1 25 | $1.5B | $883.1M | ||
| Q4 24 | $1.6B | $937.9M | ||
| Q3 24 | $1.6B | $935.0M | ||
| Q2 24 | $1.6B | $942.3M | ||
| Q1 24 | $1.6B | $908.4M |
| Q4 25 | $-205.0M | $45.6M | ||
| Q3 25 | $160.0M | $49.9M | ||
| Q2 25 | $145.0M | $45.7M | ||
| Q1 25 | $87.0M | $39.2M | ||
| Q4 24 | $109.0M | $61.0M | ||
| Q3 24 | $359.0M | $48.1M | ||
| Q2 24 | $195.0M | $37.7M | ||
| Q1 24 | $201.0M | $29.2M |
| Q4 25 | 49.2% | 51.2% | ||
| Q3 25 | 53.5% | 52.2% | ||
| Q2 25 | 54.8% | 51.5% | ||
| Q1 25 | 55.6% | 52.0% | ||
| Q4 24 | 56.3% | 50.8% | ||
| Q3 24 | 58.3% | 51.2% | ||
| Q2 24 | 58.4% | 51.0% | ||
| Q1 24 | 59.0% | 51.0% |
| Q4 25 | -9.8% | 8.1% | ||
| Q3 25 | 15.2% | 8.4% | ||
| Q2 25 | 14.4% | 8.4% | ||
| Q1 25 | 6.7% | 7.9% | ||
| Q4 24 | 8.1% | 10.7% | ||
| Q3 24 | 13.1% | 8.8% | ||
| Q2 24 | 14.6% | 7.6% | ||
| Q1 24 | 14.5% | 6.6% |
| Q4 25 | -13.6% | 4.8% | ||
| Q3 25 | 10.0% | 5.3% | ||
| Q2 25 | 9.1% | 4.9% | ||
| Q1 25 | 5.8% | 4.4% | ||
| Q4 24 | 6.8% | 6.5% | ||
| Q3 24 | 22.7% | 5.1% | ||
| Q2 24 | 12.1% | 4.0% | ||
| Q1 24 | 12.4% | 3.2% |
| Q4 25 | $-0.78 | $0.45 | ||
| Q3 25 | $0.61 | $0.49 | ||
| Q2 25 | $0.56 | $0.44 | ||
| Q1 25 | $0.33 | $0.38 | ||
| Q4 24 | $0.42 | $0.58 | ||
| Q3 24 | $1.38 | $0.45 | ||
| Q2 24 | $0.75 | $0.36 | ||
| Q1 24 | $0.78 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $157.2M |
| Total DebtLower is stronger | $8.6B | $842.5M |
| Stockholders' EquityBook value | $752.0M | $823.6M |
| Total Assets | $12.9B | $2.9B |
| Debt / EquityLower = less leverage | 11.49× | 1.02× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $157.2M | ||
| Q3 25 | $672.0M | $149.2M | ||
| Q2 25 | $599.0M | $112.8M | ||
| Q1 25 | $547.0M | $92.2M | ||
| Q4 24 | $675.0M | $105.5M | ||
| Q3 24 | $763.0M | $108.0M | ||
| Q2 24 | $704.0M | $97.4M | ||
| Q1 24 | $575.0M | $97.2M |
| Q4 25 | $8.6B | $842.5M | ||
| Q3 25 | $8.8B | $862.0M | ||
| Q2 25 | $8.9B | $882.4M | ||
| Q1 25 | $9.0B | $902.8M | ||
| Q4 24 | $8.9B | $938.1M | ||
| Q3 24 | $8.7B | $978.3M | ||
| Q2 24 | $8.7B | $978.9M | ||
| Q1 24 | $8.7B | $978.4M |
| Q4 25 | $752.0M | $823.6M | ||
| Q3 25 | $906.0M | $794.2M | ||
| Q2 25 | $733.0M | $762.9M | ||
| Q1 25 | $542.0M | $699.8M | ||
| Q4 24 | $472.0M | $656.5M | ||
| Q3 24 | $493.0M | $628.5M | ||
| Q2 24 | $144.0M | $577.7M | ||
| Q1 24 | $48.0M | $550.9M |
| Q4 25 | $12.9B | $2.9B | ||
| Q3 25 | $13.6B | $2.9B | ||
| Q2 25 | $13.5B | $2.7B | ||
| Q1 25 | $13.2B | $2.7B | ||
| Q4 24 | $13.1B | $2.7B | ||
| Q3 24 | $12.8B | $2.8B | ||
| Q2 24 | $12.2B | $2.7B | ||
| Q1 24 | $11.9B | $2.7B |
| Q4 25 | 11.49× | 1.02× | ||
| Q3 25 | 9.74× | 1.09× | ||
| Q2 25 | 12.14× | 1.16× | ||
| Q1 25 | 16.52× | 1.29× | ||
| Q4 24 | 18.81× | 1.43× | ||
| Q3 24 | 17.75× | 1.56× | ||
| Q2 24 | 60.11× | 1.69× | ||
| Q1 24 | 181.54× | 1.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $93.2M |
| Free Cash FlowOCF − Capex | $96.0M | $57.5M |
| FCF MarginFCF / Revenue | 6.4% | 6.1% |
| Capex IntensityCapex / Revenue | 3.0% | 3.8% |
| Cash ConversionOCF / Net Profit | — | 2.05× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $216.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $93.2M | ||
| Q3 25 | $264.0M | $120.9M | ||
| Q2 25 | $220.0M | $69.4M | ||
| Q1 25 | $75.0M | $51.1M | ||
| Q4 24 | $390.0M | $33.5M | ||
| Q3 24 | $141.0M | $110.7M | ||
| Q2 24 | $332.0M | $47.9M | ||
| Q1 24 | $76.0M | $36.9M |
| Q4 25 | $96.0M | $57.5M | ||
| Q3 25 | $218.0M | $78.0M | ||
| Q2 25 | $181.0M | $49.1M | ||
| Q1 25 | $43.0M | $32.2M | ||
| Q4 24 | $335.0M | $13.4M | ||
| Q3 24 | $99.0M | $73.3M | ||
| Q2 24 | $300.0M | $28.7M | ||
| Q1 24 | $30.0M | $22.8M |
| Q4 25 | 6.4% | 6.1% | ||
| Q3 25 | 13.6% | 8.2% | ||
| Q2 25 | 11.4% | 5.3% | ||
| Q1 25 | 2.8% | 3.6% | ||
| Q4 24 | 21.0% | 1.4% | ||
| Q3 24 | 6.3% | 7.8% | ||
| Q2 24 | 18.7% | 3.1% | ||
| Q1 24 | 1.8% | 2.5% |
| Q4 25 | 3.0% | 3.8% | ||
| Q3 25 | 2.9% | 4.5% | ||
| Q2 25 | 2.4% | 2.2% | ||
| Q1 25 | 2.1% | 2.1% | ||
| Q4 24 | 3.5% | 2.1% | ||
| Q3 24 | 2.7% | 4.0% | ||
| Q2 24 | 2.0% | 2.0% | ||
| Q1 24 | 2.8% | 1.6% |
| Q4 25 | — | 2.05× | ||
| Q3 25 | 1.65× | 2.42× | ||
| Q2 25 | 1.52× | 1.52× | ||
| Q1 25 | 0.86× | 1.30× | ||
| Q4 24 | 3.58× | 0.55× | ||
| Q3 24 | 0.39× | 2.30× | ||
| Q2 24 | 1.70× | 1.27× | ||
| Q1 24 | 0.38× | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
SBH
| Sally Beauty Supply | $531.6M | 56% |
| Beauty Systems Group | $411.6M | 44% |
